Royal Bank Of Canada Athersys, Inc Transaction History

Royal Bank Of Canada

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.18 - $0.86 $2,408 - $11,508	-13,382 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.6 - $1.06 $19,650 - $34,716	-32,751 Reduced 70.99%	13,382 $8,000
Q4 2021 Feb 14, 2022	BUY	$0.85 - $1.4 $18,010 - $29,664	21,189 Added 84.95%	46,133 $42,000
Q3 2021 Nov 15, 2021	BUY	$1.33 - $1.77 $11,468 - $15,262	8,623 Added 52.83%	24,944 $33,000
Q2 2021 Aug 16, 2021	BUY	$1.41 - $1.94 $23,012 - $31,662	16,321 New	16,321 $24,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.